These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 12523936

  • 1. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).
    Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden I, Schuetz JD, Borst P.
    Biochem J; 2003 Apr 15; 371(Pt 2):361-7. PubMed ID: 12523936
    [Abstract] [Full Text] [Related]

  • 2. Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11).
    Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD.
    Mol Pharmacol; 2005 Feb 15; 67(2):545-57. PubMed ID: 15537867
    [Abstract] [Full Text] [Related]

  • 3. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3).
    Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y.
    J Biol Chem; 2000 Jan 28; 275(4):2905-10. PubMed ID: 10644759
    [Abstract] [Full Text] [Related]

  • 4. Transport of amphipathic anions by human multidrug resistance protein 3.
    Zeng H, Liu G, Rea PA, Kruh GD.
    Cancer Res; 2000 Sep 01; 60(17):4779-84. PubMed ID: 10987286
    [Abstract] [Full Text] [Related]

  • 5. ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids.
    Loe DW, Almquist KC, Cole SP, Deeley RG.
    J Biol Chem; 1996 Apr 19; 271(16):9683-9. PubMed ID: 8621644
    [Abstract] [Full Text] [Related]

  • 6. Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites.
    Slot AJ, Wise DD, Deeley RG, Monks TJ, Cole SP.
    Drug Metab Dispos; 2008 Mar 19; 36(3):552-60. PubMed ID: 18079363
    [Abstract] [Full Text] [Related]

  • 7. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3).
    Grant CE, Gao M, DeGorter MK, Cole SP, Deeley RG.
    Drug Metab Dispos; 2008 Dec 19; 36(12):2571-81. PubMed ID: 18775981
    [Abstract] [Full Text] [Related]

  • 8. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
    Zhou SF, Wang LL, Di YM, Xue CC, Duan W, Li CG, Li Y.
    Curr Med Chem; 2008 Dec 19; 15(20):1981-2039. PubMed ID: 18691054
    [Abstract] [Full Text] [Related]

  • 9. Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog.
    Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, Cole SP.
    J Biol Chem; 2001 Jul 27; 276(30):27846-54. PubMed ID: 11375986
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10).
    Chen ZS, Hopper-Borge E, Belinsky MG, Shchaveleva I, Kotova E, Kruh GD.
    Mol Pharmacol; 2003 Feb 27; 63(2):351-8. PubMed ID: 12527806
    [Abstract] [Full Text] [Related]

  • 11. Construction of triple-transfected cells [organic anion-transporting polypeptide (OATP) 1B1/multidrug resistance-associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4.
    Hirouchi M, Kusuhara H, Onuki R, Ogilvie BW, Parkinson A, Sugiyama Y.
    Drug Metab Dispos; 2009 Oct 27; 37(10):2103-11. PubMed ID: 19628752
    [Abstract] [Full Text] [Related]

  • 12. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions.
    Bodo A, Bakos E, Szeri F, Varadi A, Sarkadi B.
    J Biol Chem; 2003 Jun 27; 278(26):23529-37. PubMed ID: 12704183
    [Abstract] [Full Text] [Related]

  • 13. ABCC10, ABCC11, and ABCC12.
    Kruh GD, Guo Y, Hopper-Borge E, Belinsky MG, Chen ZS.
    Pflugers Arch; 2007 Feb 27; 453(5):675-84. PubMed ID: 16868766
    [Abstract] [Full Text] [Related]

  • 14. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione.
    Rius M, Hummel-Eisenbeiss J, Hofmann AF, Keppler D.
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr 27; 290(4):G640-9. PubMed ID: 16282361
    [Abstract] [Full Text] [Related]

  • 15. Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter.
    Zelcer N, Saeki T, Bot I, Kuil A, Borst P.
    Biochem J; 2003 Jan 01; 369(Pt 1):23-30. PubMed ID: 12220224
    [Abstract] [Full Text] [Related]

  • 16. Selectivity in the Efflux of Glucuronides by Human Transporters: MRP4 Is Highly Active toward 4-Methylumbelliferone and 1-Naphthol Glucuronides, while MRP3 Exhibits Stereoselective Propranolol Glucuronide Transport.
    Järvinen E, Troberg J, Kidron H, Finel M.
    Mol Pharm; 2017 Oct 02; 14(10):3299-3311. PubMed ID: 28850245
    [Abstract] [Full Text] [Related]

  • 17. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3.
    Chu XY, Huskey SE, Braun MP, Sarkadi B, Evans DC, Evers R.
    J Pharmacol Exp Ther; 2004 Apr 02; 309(1):156-64. PubMed ID: 14722317
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3.
    Zhang DW, Gu HM, Vasa M, Muredda M, Cole SP, Deeley RG.
    Biochemistry; 2003 Aug 26; 42(33):9989-10000. PubMed ID: 12924948
    [Abstract] [Full Text] [Related]

  • 19. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.
    Keppler D.
    Handb Exp Pharmacol; 2011 Aug 26; (201):299-323. PubMed ID: 21103974
    [Abstract] [Full Text] [Related]

  • 20. Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4.
    Wittgen HG, van den Heuvel JJ, van den Broek PH, Dinter-Heidorn H, Koenderink JB, Russel FG.
    Drug Metab Dispos; 2011 Jul 26; 39(7):1294-302. PubMed ID: 21511945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.